Overview
ISO 8871-4:2006 - "Elastomeric parts for parenterals and for devices for pharmaceutical use - Part 4: Biological requirements and test methods" defines the biological safety requirements and test methods for elastomeric components used in direct contact with parenteral and pharmaceutical products. It specifies extraction procedures, references pharmacopoeial and ISO biological test instructions, and complements other parts of ISO 8871 that cover extractables, identification, particle release and functional testing.
Key topics and requirements
- Biological requirements: Materials shall not release substances that adversely affect therapeutic effectiveness or safety, including toxic or pyrogenic agents.
- Test selection and interpretation: Choice of tests depends on material composition and exposure conditions (nature, frequency, duration).
- Hierarchical toxicity testing:
- In vitro cytotoxicity (Annex B): Primary screen performed per USP <87> or ISO 10993-5. If non-cytotoxic, no further in vivo testing is required.
- In vivo testing (Annex C & D): If cytotoxicity is observed, perform intracutaneous (local) and systemic toxicity tests following USP <88>.
- Endotoxins and bioburden:
- Extractable bacterial endotoxins (Annex A): Extraction in endotoxin-free water and measurement using LAL methods as per USP <85> or Ph.Eur. 2.6.14. Limits (EU/cm2 or EU/ml) are to be agreed between supplier and user; methods must be validated.
- Bioburden monitoring: Colony-forming unit (cfu) limits are agreed between supplier and user; ISO 11737-1 provides guidance on method validation.
- Extraction procedures: The standard supplies extraction guidance (e.g., surface-area-based extraction, handling of complex cavities) and notes when cutting parts may be necessary to ensure adequate recovery.
- Validation & reference methods: All analytical and biological methods used should be validated and assessed against USP/Ph.Eur. and ISO biological test criteria.
Applications
ISO 8871-4:2006 is applied to elastomeric closures and components such as:
- Rubber stoppers and vial closures for parenteral drugs
- Syringe seals, needle shields, freeze-drying closures, and other elastomeric parts in pharmaceutical devices
- Quality control and release testing of primary packaging in sterile drug manufacturing
Who should use this standard
- Pharmaceutical manufacturers and quality assurance teams
- Elastomer/rubber component suppliers and formulators
- Medical device and parenteral packaging manufacturers
- Analytical and biological testing laboratories
- Regulatory affairs and compliance specialists assessing primary packaging safety
Related standards
- ISO 8871 (Parts 1–5) - full suite on elastomeric parts
- ISO 10993-5 - in vitro cytotoxicity
- ISO 11737-1 - bioburden determination guidance
- USP chapters <85>, <87>, <88> and Ph.Eur. bacterial endotoxins chapter - referenced test methods
Keywords: ISO 8871-4:2006, elastomeric parts, parenterals, biological requirements, test methods, cytotoxicity, endotoxins, bioburden, USP, Ph.Eur., LAL, extraction procedures.
Open preview (PDF)Elastomeric parts for parenterals and for devices for pharmaceutical use — Part 4: Biological requirements and test methods